Synthetic Genomics Recruits Illumina Exec

Bruce V. Bigelow2/23/10

Synthetic Genomics, the San Diego biofuels developer, today named a top executive from San Diego-based Illumina (NASDAQ: ILMN), the maker of genetic sequencing tools, as its chief operating officer. Joel McComb, a senior vice president and general manager of Illumina’s $650 million life sciences business unit, will start March 1 and report to J. Craig Venter, Synthetic Genomics founder and CEO.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788